|
|
|
Corporate Profile: Cortex
Pharmaceuticals
| Summary: |
Cortex believes
that increasing AMPA receptor activity with AMPAKINEs
will provide a new approach to treating a number of
central nervous system disorders. |
| Address:
|
15231 Barranca Parkway
Irvine, CA 92618 |
| Phone
#'s: |
Main |
(949) 727-3157 |
| Human Resources |
not known |
| Investor Relations |
(949) 727-3157 |
| Fax
#'s: |
Main |
(949) 727-3657 |
| Human Resources |
(949) 727-3657 |
| Investor Relations |
(949) 727-3657 |
| Financial
information: |
| COR |
| Issued United States patents: |
Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
|
|
|
